BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 22716170)

  • 21. Decreased INR response secondary to warfarin-flucloxacillin interaction.
    Garg A; Mohammed M
    Ann Pharmacother; 2009 Jul; 43(7):1374-5. PubMed ID: 19584391
    [No Abstract]   [Full Text] [Related]  

  • 22. Hemorrhage during warfarin therapy associated with cotrimoxazole and other urinary tract anti-infective agents: a population-based study.
    Fischer HD; Juurlink DN; Mamdani MM; Kopp A; Laupacis A
    Arch Intern Med; 2010 Apr; 170(7):617-21. PubMed ID: 20386005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Warfarin versus low-molecular-weight heparin therapy in cancer patients.
    Zacharski LR; Prandoni P; Monreal M
    Oncologist; 2005 Jan; 10(1):72-9. PubMed ID: 15632254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The nature and frequency of potential warfarin drug interactions that increase the risk of bleeding in patients with atrial fibrillation.
    Howard PA; Ellerbeck EF; Engelman KK; Patterson KL
    Pharmacoepidemiol Drug Saf; 2002; 11(7):569-76. PubMed ID: 12462133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction between warfarin and cranberry juice.
    Aston JL; Lodolce AE; Shapiro NL
    Pharmacotherapy; 2006 Sep; 26(9):1314-9. PubMed ID: 16945054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adverse interactions between warfarin and nonsteroidal antiinflammatory drugs: mechanisms, clinical significance, and avoidance.
    Chan TY
    Ann Pharmacother; 1995 Dec; 29(12):1274-83. PubMed ID: 8672833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated international normalized ratio associated with use of dronedarone and warfarin.
    Pogge EK; Haber SL
    Ann Pharmacother; 2011 Sep; 45(9):e46. PubMed ID: 21811004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Warfarin pharmacology, clinical management, and evaluation of hemorrhagic risk for the elderly.
    Jacobs LG
    Clin Geriatr Med; 2006 Feb; 22(1):17-32, vii-viii. PubMed ID: 16377465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction between warfarin and levofloxacin: case series.
    Vadlamudi RS; Smalligan RD; Ismail HM
    South Med J; 2007 Jul; 100(7):720-4. PubMed ID: 17639754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Concomitant use of warfarin, analgesics and anti-inflammatory agents].
    HÃ¥konsen GD; Pettersen MH; Skurtveit S; Giverhaug T
    Tidsskr Nor Laegeforen; 2009 Jun; 129(12):1217-20. PubMed ID: 19521444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multisite mucous membrane bleeding due to a possible interaction between warfarin and 5-fluorouracil.
    Brown MC
    Pharmacotherapy; 1997; 17(3):631-3. PubMed ID: 9165571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic and pharmacodynamic study of interaction of Rhodiola rosea SHR-5 extract with warfarin and theophylline in rats.
    Panossian A; Hovhannisyan A; Abrahamyan H; Gabrielyan E; Wikman G
    Phytother Res; 2009 Mar; 23(3):351-7. PubMed ID: 18844284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of upper gastrointestinal hemorrhage in warfarin users treated with nonselective NSAIDs or COX-2 inhibitors.
    Battistella M; Mamdami MM; Juurlink DN; Rabeneck L; Laupacis A
    Arch Intern Med; 2005 Jan; 165(2):189-92. PubMed ID: 15668365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced hypoprothrombinemia with warfarin due to azithromycin.
    Rao KB; Pallaki M; Tolbert SR; Hornick TR
    Ann Pharmacother; 2004 Jun; 38(6):982-5. PubMed ID: 15084685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Warfarin treatment and bleeding].
    Breen AB; Vaskinn TE; Reikvam A; Skovlund E; Lislevand H; Madsen S
    Tidsskr Nor Laegeforen; 2003 Jun; 123(13-14):1835-7. PubMed ID: 12830257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction between warfarin and tamoxifen: a case report.
    Mishra D; Paudel R; Kishore PV; Palaian S; Bista D; Misra P
    Kathmandu Univ Med J (KUMJ); 2007; 5(1):105-7. PubMed ID: 18603996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Possible warfarin failure due to interaction with smokeless tobacco.
    Kuykendall JR; Houle MD; Rhodes RS
    Ann Pharmacother; 2004 Apr; 38(4):595-7. PubMed ID: 14766993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fecal hemoglobin excretion in elderly patients with atrial fibrillation: combined aspirin and low-dose warfarin vs conventional warfarin therapy.
    Blackshear JL; Baker VS; Holland A; Litin SC; Ahlquist DA; Hart RG; Ellefson R; Koehler J
    Arch Intern Med; 1996 Mar; 156(6):658-60. PubMed ID: 8629878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Critically elevated INR in a patient on warfarin after increase in extended-release niacin dose.
    Christopher A
    Ann Pharmacother; 2011 Nov; 45(11):e58. PubMed ID: 22010004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unusual hypersensitivity to warfarin in a critically ill patient.
    Konishi H; Eguchi Y; Fujii M; Saotome T; Sasaki T; Takahashi K; Sudo M; Morii H; Minouchi T; Yamaji A
    J Clin Pharm Ther; 2004 Oct; 29(5):485-90. PubMed ID: 15482394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.